Seeing Is Saving: Navigating the Rocky Path With Intravascular Ultrasound Authors: Oh-Hyun Lee Published: 2026 Coronary artery calcification (CAC) remains a daily challenge for interventional cardiologists.1) As the global population ages, the prevalence of severely calcified lesions are increasing, with CAC observed in approximately 40% of patients undergoing coronary angiography and in over 70% of lesions evaluated with intravascular imaging.2) These calcified lesions are associated with increased immediate complications including stent underexpansion, dissection and catastrophic long-term clinical outcomes such as stent thrombosis, repeat revascularization, and sudden cardiac death. To address moderate to severe calcified plaques, rotational atherectomy (RA) has served as a definitive tool for decades. Nevertheless, RA remains a high-risk procedure, associated with potential complications including vessel perforation, the no-reflow phenomenon, and periprocedural myocardial infarction.3) In this clinical setting, relying solely on 2 dimensional angiography is insufficient for evaluating complex disease morphology, plaque composition, plaque burden, or accurate stent sizing, highlighting the necessity for the clarity provided by intravascular imaging. Recent randomized controlled trials (RCTs) have demonstrated the significant benefits of imaging guided-percutaneous coronary intervention (PCI) compared to angiographic guidance alone, especially in complex lesions subsets.4),5) However, the efficacy of imaging guidance in moderately to severely calcified lesions remains poorly established, primarily attributable to small, underpowered subsets. In a comprehensive analysis of the multicenter ROCK registry, Jang et al.6) showed that intravascular ultrasound (IVUS) guidance significantly reduces the 3-year risk of cardiac death or myocardial infarction compared to angiography alone (hazard ratio, 0.44; 95% confidence interval [CI], 0.23–0.87; p=0.02). These findings align with a recent network meta-analysis of RCTs evaluating the impact of imaging-guided PCI on major adverse cardiovascular events (MACE) in patients with various complex lesion subsets.7) This meta-analysis showed that both IVUS (relative risk [RR], 0.61; 95% CI, 0.38–0.98; p=0.04) and optical coherence tomography (OCT) guidance (RR, 0.66; 95% CI, 0.44–0.98; p=0.04) significantly reduce the risk of MACE compared to angiography in patients with moderately to severely calcified lesions, with no significant difference observed between 2 imaging modalities. Notably, although stent optimization was achieved in only 24.8% of patients and suboptimal results were associated with a higher incidence of adverse events, IVUS guidance improved clinical outcomes compared to the angiography alone. This suggest that even incremental, imaging-driven improvements, including identifying edge dissections or the attainment of a larger luminal area, translate into better clinical outcomes. Ultimately, these robust clinical benefits give us a critical message that IVUS is an essential requirement for optimizing long-term outcomes in the challenging environment of calcified coronary lesions. Moving forward, prospective randomized trials are necessary to confirm these findings. The low rate of stent optimization suggests that standard targets may be inappropriate for severely calcified lesions, necessitating the development of lesion-specific optimization criteria that are both realistic and prognostic. Conventional optimization criteria, most commonly a minimal stent area exceeding 80% of the average reference lumen area, are frequently unattainable within a rigid, non-compliant calcified ring that mechanically resists full expansion despite high pressure post-dilatation.8) In this context, calcium fracture demonstrated on intravascular imaging after adequate lesion preparation may represent a more realistic and mechanistically relevant target, as fracture of the calcified plate permits the acute luminal area gain and symmetric stent expansion that ultimately determine long-term outcomes.9) While the adoption of advanced calcium modification devices such as orbital atherectomy and intravascular lithotripsy is essential for effective lesion preparation, the fundamental requirement of imaging-guided optimization remains the cornerstone of procedural success. Beyond confirming the need for calcium modification, imaging also indicates which strategy to employ. By delineating the arc, distribution, and eccentricity of calcium and by identifying calcified nodules, IVUS helps distinguish lesions best managed by RA, including superficial calcium, and uncrossable or undilatable lesions requiring surface ablation, from those suited to intravascular lithotripsy, in which both superficial and deep calcium can be fractured once a balloon crosses the lesion.1) Because acoustic shadowing limits the measurement of calcium thickness by IVUS, complementary OCT further sharpens this decision, as thinner calcific plates (<0.5 mm) tend to fracture readily whereas thicker plates favor debulking by atherectomy.8) Ultimately, the shift from angiographic guidance to imaging guidance is no longer a matter of choice, but a clinical requirement to overcome the physical resistance of calcified coronary disease. Footnotes Funding: The author received no financial support for the research, authorship, and/or publication of this article. Conflict of Interest: The author has no financial conflicts of interest. Data Sharing Statement: The data generated in this study is available from the corresponding author upon reasonable request. The contents of the report are the author's own views and do not necessarily reflect the views of the Korean Circulation Journal. References